Axonal regeneration promotion

"Axonal regeneration promotion" refers to the therapeutic pursuit of enhancing the intrinsic and extrinsic molecular pathways that allow neurons to regenerate their axons after injury. This process involves complex, temporally and spatially coordinated molecular mechanisms—such as mTOR signaling (e.g., PTEN inhibition or melanopsin activation), epigenetic modifications (e.g., histone acetylation via p300 or PCAF), extracellular signaling (e.g., GPCRs, integrin pathways, RhoA signaling), and cell-intrinsic reprogramming factors (e.g., Lin28, c-Myc, STAT3)—to promote axon regrowth and functional repair after central or peripheral nerve injury[1][2][3][4][5]. There is no single “axonal regeneration promotion” receptor or target; rather, it is a multi-factorial process and not a discrete molecular entity.